Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$759.15
-0.12%
Mkt Cap $78.57B
Analyst Ratings
Buy
21
Hold
7
Sell
0
Price Target (130 analysts)
$836.00
Range $641.00 – $995.00
Implied Upside
+10.1%
Consensus $836.00 vs current $759.15